Case Study:

Dermagnostix — Empowering Dermatology Innovation

Dermagnostix is pioneering molecular diagnostics in dermatology to advance clinical practice and improve patients’ lives.

Company Size:

> 25 Employees

Total Revenue:

> € 10M




Dermagnostix, located in Southern Germany, are on a mission to bridge the divide between modern therapeutic advances and diagnostic methods that haven’t evolved at the same pace. Their cutting-edge technology empowers physicians to make efficient skin diagnoses, enabling dermatology professionals and research organizations to offer innovative diagnostic solutions at scale and improve patients’ lives.

AOA Positive Impacts

Scroll to Top